Loading...
Header Logo
Keywords
Last Name
Institution

Dr Christine Manyando

Title[no position]
Institution[no institution name]
Address[no address]
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Phillips MA, Burrows JN, Manyando C, van Huijsduijnen RH, Van Voorhis WC, Wells TNC. Malaria. Nat Rev Dis Primers. 2017 Aug 03; 3:17050. PMID: 28770814.
      View in: PubMed
    2. Dellicour S, Sevene E, McGready R, Tinto H, Mosha D, Manyando C, Rulisa S, Desai M, Ouma P, Oneko M, Vala A, Rupérez M, Macete E, Menéndez C, Nakanabo-Diallo S, Kazienga A, Valéa I, Calip G, Augusto O, Genton B, Njunju EM, Moore KA, d'Alessandro U, Nosten F, Ter Kuile F, Stergachis A. First-trimester artemisinin derivatives and quinine treatments and the risk of adverse pregnancy outcomes in Africa and Asia: A meta-analysis of observational studies. PLoS Med. 2017 05; 14(5):e1002290. PMID: 28463996.
      View in: PubMed
    3. Mwanza S, Joshi S, Nambozi M, Chileshe J, Malunga P, Kabuya JB, Hachizovu S, Manyando C, Mulenga M, Laufer M. The return of chloroquine-susceptible Plasmodium falciparum malaria in Zambia. Malar J. 2016 Dec 05; 15(1):584. PMID: 27919256.
      View in: PubMed
    4. Mulenga M, Manyando C. Mounting evidence for use of artemisinin derivatives for malaria in early pregnancy. Lancet Infect Dis. 2016 05; 16(5):513-515. PMID: 26869379.
      View in: PubMed
    5. Manyando C, Njunju EM, Virtanen M, Hamed K, Gomes M, Van Geertruyden JP. Exposure to artemether-lumefantrine (Coartem) in first trimester pregnancy in an observational study in Zambia. Malar J. 2015 Feb 14; 14:77. PMID: 25877884.
      View in: PubMed
    6. Manyando C, Njunju EM, Mwakazanga D, Chongwe G, Mkandawire R, Champo D, Mulenga M, De Crop M, Claeys Y, Ravinetto RM, van Overmeir C, Alessandro UD, Van Geertruyden JP. Safety of daily co-trimoxazole in pregnancy in an area of changing malaria epidemiology: a phase 3b randomized controlled clinical trial. PLoS One. 2014; 9(5):e96017. PMID: 24830749.
      View in: PubMed
    7. Manyando C, Njunju EM, Chileshe J, Siziya S, Shiff C. Rapid diagnostic tests for malaria and health workers' adherence to test results at health facilities in Zambia. Malar J. 2014 May 02; 13:166. PMID: 24885996.
      View in: PubMed
    8. Manyando C, Njunju EM, D'Alessandro U, Van Geertruyden JP. Safety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: a systematic review. PLoS One. 2013; 8(2):e56916. PMID: 23451110.
      View in: PubMed
    9. Manyando C, Kayentao K, D'Alessandro U, Okafor HU, Juma E, Hamed K. A systematic review of the safety and efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria during pregnancy. Malar J. 2012 May 01; 11:141. PMID: 22548983.
      View in: PubMed
    10. Manyando C, Mkandawire R, Puma L, Sinkala M, Mpabalwani E, Njunju E, Gomes M, Ribeiro I, Walter V, Virtanen M, Schlienger R, Cousin M, Chipimo M, Sullivan FM. Safety of artemether-lumefantrine in pregnant women with malaria: results of a prospective cohort study in Zambia. Malar J. 2010 Sep 01; 9:249. PMID: 20809964.
      View in: PubMed
    11. Falade C, Manyando C. Safety profile of Coartem: the evidence base. Malar J. 2009 Oct 12; 8 Suppl 1:S6. PMID: 19818173.
      View in: PubMed
    12. Matee MI, Manyando C, Ndumbe PM, Corrah T, Jaoko WG, Kitua AY, Ambene HP, Ndounga M, Zijenah L, Ofori-Adjei D, Agwale S, Shongwe S, Nyirenda T, Makanga M. European and Developing Countries Clinical Trials Partnership (EDCTP): the path towards a true partnership. BMC Public Health. 2009 Jul 20; 9:249. PMID: 19619283.
      View in: PubMed
    13. Simpson JA, Hughes D, Manyando C, Bojang K, Aarons L, Winstanley P, Edwards G, Watkins WA, Ward S. Population pharmacokinetic and pharmacodynamic modelling of the antimalarial chemotherapy chlorproguanil/dapsone. Br J Clin Pharmacol. 2006 Mar; 61(3):289-300. PMID: 16487222.
      View in: PubMed
    14. Na-Bangchang K, Manyando C, Ruengweerayut R, Kioy D, Mulenga M, Miller GB, Konsil J. The pharmacokinetics and pharmacodynamics of atovaquone and proguanil for the treatment of uncomplicated falciparum malaria in third-trimester pregnant women. Eur J Clin Pharmacol. 2005 Sep; 61(8):573-82. PMID: 16041597.
      View in: PubMed
    15. Kaona F, Siajunza MT, Manyando C, Khondowe S, Ngoma GK. Utilisation of malarial drugs at a household level: results from a KAP study in Choma, southern province and Mporokoso, northern province of Zambia. Cent Afr J Med. 2000 Oct; 46(10):268-70. PMID: 11682934.
      View in: PubMed
    16. Puta C, Manyando C. Enhanced gametocyte production in Fansidar-treated Plasmodium falciparum malaria patients: implications for malaria transmission control programmes. Trop Med Int Health. 1997 Mar; 2(3):227-9. PMID: 9491100.
      View in: PubMed
    17. Kafwembe EM, Sukwa TY, Manyando C, Mwandu D, Chipipa J, Chipaila P. The vitamin A status of Zambian children attending an under five clinic as evaluated by the modified relative dose response (MRDR) test. Int J Vitam Nutr Res. 1996; 66(3):190-6. PMID: 8899450.
      View in: PubMed
    Manyando's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description